Schedule 13G ownership disclosure
SERES THERAPEUTICS INC
Security class unavailable · CUSIP: 81750R102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,676,265
- Percent of class
- 5.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-018542
- Form type
- SC 13G
- Filer
- Seres Therapeutics, Inc.
- CIK
- CIK 1609809
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership